Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: Results from three randomized clinical trials, SAVE-HIP1, SAVE-HIP2 and SAVE-KNEE

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 5, 2012, Pages 822-832

  Lassen, M R ^a   Fisher, W ^b,i   Mouret, P ^c   Agnelli, G ^d   George, D ^e   Kakkar, A ^f   Mismetti, P ^g   Turpie, A G G ^h   Leizorovicz, A ⁱ   Borris, L C ⁱ   Buyse, M ⁱ   Sturbois, G ⁱ   Fisher, M R ⁱ   White, R H ⁱ   Alvarisqueta , A ⁱ   Horsley, M ⁱ   Jackson, D ⁱ   Salem, H ⁱ   Chong, B ⁱ   Richards, B ⁱ   Baltrukevich, S ⁱ   Pisesky, W ⁱ   Kim, P ^i,i,i   Martinez, S ^i,i   Aguilera, B ^i,i,i   Rocha, C ⁱ   Reyes, A ^i,i   Botero Lopez, R ⁱ   Trc, T ^i,i   Pink, T ⁱ   Ludvik, J ⁱ   Krbec, M ^i,i   Repko, M ^i,i   Mikkelsen, S ^i,i   Gebuhr, P ^i,i,i   Lassen, M ^i,i   Borgwardt, A ⁱ   Martson A ^i,i   Kelk, M ⁱ   Koop A ^i,i   Tyllianakis, M ^i,i   Kapetanos, G ^i,i,i   Christodoulou, A ^i,i,i   Kocius, M ⁱ   Smailys, A ⁱ   Sierra Perez, M ⁱ   Gomez Sanchez, E ^i,i,i   Vazquez Montana, M ⁱ   Resendiz Orozco, S ⁱ   Ramos Morales, T ⁱ   Berumen Nafarrate, E ⁱ   Synder, M ^i,i   Skowronski, J ^i,i,i   Kruczynski, J ^i,i,i   Blacha, J ⁱ   Kwiatkowski, K ^i,i   Tkaczyk, S ^i,i,i   Cirstoiu, C ^i,i,i   Popescu, G ^i,i,i   Purghel, F ⁱ   Botez, P ⁱ   Vermesan, H ⁱ   Poenaru, D ^i,i,i   Yakusevich, V ⁱ   Akhtyamov, I ⁱ   Zagorodniy, N ⁱ   Kornilov, N ^i,i,i   Linnik, S ^i,i   Ivanov, P ^i,i,i   Dryagin, V ⁱ   Safronov, A ^i,i,i   Magomedov, K ^i,i   Murylev, V ^i,i   Parfeev, S ⁱ   Ezhov, I ^i,i   Kuropatkin, G ⁱ   Abolin, A ⁱ   Van zyl, L ^i,i,i   Oelofse, L ⁱ   Swart, H J ⁱ   Stathoulis, B ⁱ   Sulyma, V ⁱ   Kostrub, O ⁱ   Shyshka, I ⁱ   Chernyak, V ^i,i,i   Olinichenko, G ⁱ   Korzh, M ⁱ   Browne, R ^i,i   Murray, R M ⁱ   Ward, J ^i,i,i   Williams, D ^i,i,i   Strain, R ^i,i   Gimbel, J ^i,i   Tapadiya, D ⁱ   Hollmann, M ^i,i   Jove, M ^i,i   Berkowitz, R ^i,i   Kilgore, J ^i,i   Dabezies, E ⁱ   D'angelo, G ⁱ   Minkowitz, H ^i,i   King, R ⁱ   Han, D ⁱ   Gill, G ⁱ   Lorch, D ⁱ   Siff, S ⁱ   Shah, M ⁱ   Jazayeri, M J ⁱ   Cottrell, W ⁱ   Steinman, H ⁱ   Papilion, J ⁱ   Poole, C ⁱ   Schwappach, J ⁱ   Tetsworth, K ⁱ   Carroll, P ⁱ   Kezlia, A ⁱ   Guerrero, C ⁱ   Soza, F ⁱ   Paredes, O ^i,i   Amenabar, P ⁱ   Sanchez, A ⁱ   Perez, R ⁱ   Botero, R ⁱ   Filip, L ⁱ   Kana, J ⁱ   Jensen, N ⁱ   Soballe K ⁱ   Leppilahti, J ⁱ   Vaananen H ⁱ   Jokipii, P ⁱ   Pesola, M ⁱ   Kroger H ⁱ   Kurth, A ⁱ   Lutzner J ⁱ   Craiovan, B ⁱ   Graichen, H ⁱ   Perka, C ⁱ   Verettas, D ⁱ   Babis, G ⁱ   Dadi, A ^i,i   Rajagopalan, I ⁱ   Shah, H ⁱ   Raju, P ⁱ   Shah, V ⁱ   Tapasvi, S ⁱ   Pagare, S ⁱ   Boddapalli, U ⁱ   Borghi, B ^i,i   Grossi, P ⁱ   Parise, P ⁱ   Silingardi, M ⁱ   Buffone, A ⁱ   Davia G ⁱ   Fattorini, F ⁱ   Zuqui, M A ⁱ   Berumen Nafarrete, E ⁱ   Sepulveda Oyervides, V ⁱ   Melby, B ⁱ   Sletten, S ⁱ   Dietze, A ⁱ   Lian, O ⁱ   Risberg, E ⁱ   Alfredo Arones, V ⁱ   Cotrina, R ⁱ   Marticorena, O ⁱ   Molano, A M ⁱ   San Pedro, P C ⁱ   Tarnau, A ⁱ   Steno, B ⁱ   Knapec, L ⁱ   Ozorak, M ⁱ   Mclennan Smith, R A ⁱ   Peidro, L ⁱ   Castellet, E ⁱ   Gomar, F ⁱ   Fernandez De Retana, P ⁱ   Ryttberg, L ⁱ   Horn Af, A ⁱ   Minne, B ⁱ   Nilsson, K ⁱ   Johansson, J ⁱ   Chen, Y J ⁱ   Thanainit, C ⁱ   Tanavalee, A ⁱ   Altintas, F ^i,i   Aydogdu, S ⁱ   Alpaslan, M ⁱ   Tozun, R ⁱ   Erdemli, B ⁱ   Skobenko, O ⁱ   Gerasimenko, S ⁱ   Polyvoda, O ⁱ   Chornyy, V ⁱ   Murray, R ⁱ   Boshnakov, D ⁱ   Iotov, A ⁱ   Penchev, P ⁱ   Belzile, E ⁱ   Bredo, L ⁱ   Azar, C ⁱ   Botello, E ⁱ   Tang, P ⁱ   Jiang, B ⁱ   Zhou, F ⁱ   Xu, Y ⁱ   Chen, T ⁱ   Liu, F ⁱ   Liao, W ⁱ   Leal, E ⁱ   Salas, G ⁱ   Krivohlavek, M ⁱ   Mahovsky, D ⁱ   Divis, P ⁱ   Sir, M ⁱ   Duus, B ⁱ   Overgaard, S ⁱ   Madsen, B ⁱ   Pesola M , ⁱ   Malizos, K ⁱ   Kyriakidis, A ⁱ   Naresh, S ⁱ   Peddyreddy, G R ⁱ   Bharat M , ⁱ   Sushrut, B ⁱ   Kumar, A ⁱ   Mutha, S ⁱ   D'Ambrosio, A ⁱ   Miletto, A ⁱ   Guido, G ⁱ   Brunetto, B ⁱ   Saenz Cabrera, V M ⁱ   Hernandez Ramirez, J ⁱ   Otsuka de HoyosR , ⁱ   Leal Rojas, E ⁱ   Tochio, C ⁱ   Monteiro, J ⁱ   Felicissimo, P ⁱ   Nascimento, A ⁱ   Sergeev, S ⁱ   Rodoman, G ⁱ   Belenkiy, I ⁱ   Savintsev, A ⁱ   Jansen van rensburg, J H ⁱ   Lukhele, M ⁱ   Salvador, A ⁱ   Pettersson, L ⁱ   Horn, A F A ⁱ   Durak, K ⁱ   Avkan, C ⁱ   Gurbuz, H ⁱ   Ozturk, I ⁱ   Ozkan, Y ⁱ   Ustaoglu, G ⁱ   Gatsak, V ⁱ   Krumins, K ⁱ   more..

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c SANOFI   (France)

^d UNIVERSITY OF PERUGIA   (Italy)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

^g UNIVERSITÉ JEAN MONNET   (France)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ NONE

Author keywords

Anticoagulant; Enoxaparin; Orthopedic surgery; Prophylaxis; Semuloparin; Venous thromboembolism

Indexed keywords

ENOXAPARIN; SEMULOPARIN;

ADULT; AGED; ARTICLE; BLEEDING; CAUSE OF DEATH; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; ELECTIVE SURGERY; FEMALE; HIP ARTHROPLASTY; HIP FRACTURE; HUMAN; INCIDENCE; KNEE ARTHROPLASTY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; ORTHOPEDIC SURGERY; PHASE 3 CLINICAL TRIAL (TOPIC); PHLEBOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); THROMBOCYTOPENIA; VENOUS THROMBOEMBOLISM;

EID: 84860440559     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04701.x     Document Type: Article

References (13)

1. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW; American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (Suppl. 6): 381S-453S.
2. Cardiovascular Disease Educational and Research Trust; Cyprus Cardiovascular Disease Educational and Research Trust; European Venous Forum; International Surgical Thrombosis Forum; International Union of Angiology; Union Internationale de Phlébologie. Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol 2006; 25: 101-61.
3. Viskov C, Just M, Laux V, Mourier P, Lorenz M. Description of the chemical and pharmacological characteristics of a new hemisynthetic ultra-low-molecular-weight heparin, AVE5026. J Thromb Haemost 2009; 7: 1143-51.
4. Dubruc C, Karimi-Anderesi N, Lunven C, Zhang M, Grossmann M, Potgieter H. Pharmacokinetics of a new, ultra-low molecular weight heparin, semuloparin (AVE5026), in healthy subjects. Results from the first phase I studies. Blood 2009; 114: 1073 [abstract].
5. Lassen MR, Dahl OE, Mismetti P, Destrée D, Turpie AG. AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery - TREK: a dose-ranging study. J Thromb Haemost 2009; 7: 566-72.
6. Lassen MR, Agnelli G, Fisher W, George D, Kakkar A, Mismetti P, Mouret P, Lawson F, Turpie AGG. The ultra-low-molecular weight heparin (ULMWH) semuloparin for prevention of venous thromboembolism (VTE) after elective knee replacement surgery. Pathophysiol Haemost Thromb 20092010; 37(Suppl. 1): 131-58. OC331.
7. Mouret P, Agnelli G, Fisher W, George D, Kakkar A, Lassen MR, Mismetti P, Lawson F, Turpie AGG. The ultra-low-molecular weight heparin (ULMWH) semuloparin for prevention of venous thromboembolism (VTE) after elective hip replacement surgery. Pathophysiol Haemost Thromb 20092010; 37(Suppl. 1): 131-58. OC316.
8. Fisher W, Agnelli G, George D, Kakkar A, Lassen MR, Mismetti P, Mouret P, Destrée D, Turpie AGG. The ultra-low-molecular weight heparin (ULMWH) semuloparin for prevention of venous thromboembolism (VTE) after hip fracture surgery. Pathophysiol Haemost Thromb 20092010; 37(Suppl. 1): 203-46. P330.
9. Rabinov K, Paulin S. Roentgen diagnosis of venous thrombosis in the leg. Arch Surg 1972; 104: 134-44.
10. Howard AW, Aaron SD. Low molecular weight heparin decreases proximal and distal deep venous thrombosis following total knee arthroplasty. A meta-analysis of randomized trials. Thromb Haemost 1998; 79: 902-6.
11. Handoll HH, Farrar MJ, McBirnie J, Tytherleigh-Strong G, Milne AA, Gillespie WJ. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. Cochrane Database Syst Rev 2002; 4: CD000305.
12. RE-MOBILIZE Writing Committee, Ginsberg JS, Davidson BL, Comp PC, Francis CW, Friedman RJ, Huo MH, Lieberman JR, Muntz JE, Raskob GE, Clements ML, Hantel S, Schnee JM, Caprini JA. Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. J Arthroplasty 2009; 24: 1-9.
13. Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Portman RJ. Apixaban or enoxaparin for thromboprophylaxis after knee replacement. N Engl J Med 2009; 361: 594-604.